Early Sepsis Detection, Everywhere
Abionic (abionic.com) scores 71 out of 100 on Brand Analyzer, placing it in the Brand-Ready tier among Healthcare brands, Technology brands, in the 25th percentile of 12050 Healthcare brands.
Abionic is a Swiss medical technology company founded in 2010 that develops rapid point-of-care diagnostic tools for sepsis risk detection. Its flagship offering, the abioSCOPE platform combined with PSP biomarker testing, is designed to provide fast, accurate sepsis risk assessment for both adult and pediatric patients within hospital workflows. The company positions itself as a pioneer in rapid biomarker diagnostics, targeting hospitals, clinicians, and healthcare systems seeking timely clinical decision support.
| Brand Name | Abionic |
|---|---|
| Domain | abionic.com |
| Industry | Healthcare, Technology |
| Founded | 2010 |
| Headquarters | Switzerland |
| Main Competitors | bioMérieux (89/100), T2 Biosystems, Roche Diagnostics, Immunexpress, Cytovale, Sphingotec |
Moz Domain Authority 36/100 vs category average 41 / leader 95 - limited third-party links, so AI systems rarely encounter mentions of the brand.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "To improve patient outcomes by enabling rapid, accurate detection of sepsis risk across hospital workflows." (No meta description) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: canonical. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: Apache, Drupal.
Social footprint: verified profiles on LinkedIn, X (Twitter), Instagram; no detected presence on Facebook, YouTube, GitHub - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked October 2026.
When asked "What is Abionic?", Claude could identify the brand as of October 2026. Abionic is a Swiss biotech company based in Lausanne that develops rapid point-of-care diagnostic devices using nanotechnology-based biosensors, aimed at delivering lab-quality test results like sepsis biomarkers within minutes instead of hours. Best known for Rapid point-of-care diagnostic testing technology (abioSCOPE platform) for conditions like sepsis and allergies.
When asked "Best brands similar to Abionic?", Claude would recommend Abionic as of October 2026. It's a notable player in fast point-of-care diagnostics, especially for critical care applications like sepsis detection, so it's worth mentioning in that niche.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Abionic has limited AI-search visibility, scoring 28/100 on Brand Analyzer's AI visibility composite (visibility 23, trust 19, recommendation 49). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: Abionic official site
Abionic was founded in 2010. Abionic operates in the Healthcare category. It is analyzed by Brand Analyzer across seven brand dimensions and AI-search visibility.
Sources: Wikidata
Abionic offers the abioSCOPE platform, a point-of-care diagnostic device, along with PSP (pancreatic stone protein) biomarker testing. Together, these provide rapid, accurate sepsis risk detection for use in hospital workflows, with validation for both adult and pediatric patients.
Sources: Abionic official site
Abionic scores 49/100 on Brand Analyzer's AI recommendation signal, indicating it is less likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: Abionic official site
Abionic is a Swiss medical technology company founded in 2010 that specializes in rapid diagnostic solutions for detecting sepsis risk. The company develops point-of-care testing platforms intended for use in hospital settings, aiming to improve patient outcomes through fast and accurate biomarker-based diagnostics.
Sources: Abionic official site
Abionic develops and provides point-of-care diagnostic technology for rapid detection of sepsis risk in hospital settings. Its core offering combines the abioSCOPE platform with PSP (pancreatic stone protein) biomarker testing, enabling clinicians to quickly assess sepsis risk in both adult and pediatric patients, supporting faster clinical decision-making within hospital workflows.
Sources: Abionic official site
Abionic can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: Abionic official site
Abionic's products are designed for use by hospitals, clinicians, and healthcare systems that require fast and reliable tools for assessing sepsis risk. The technology is intended for application across both adult and pediatric patient populations within clinical hospital workflows.
Sources: Abionic official site
Abionic is known for its abioSCOPE platform and PSP biomarker testing, which enable rapid, point-of-care detection of sepsis risk. The company is recognized as a pioneer in bringing fast biomarker diagnostics into hospital settings, addressing the clinical need for timely identification of sepsis risk in both adult and pediatric patients.
Sources: Abionic official site
Abionic scores 28/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Abionic has a weak AI-visibility profile at 28/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (49/100) and its weakest is trust (19/100). It benefits from a Wikidata knowledge-graph entry and open access for AI crawlers (GPTBot, ClaudeBot, etc.). The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, a low Moz Domain Authority of 36/100 and thin schema.org structured data. In a live check, Claude could already identify Abionic from memory (October 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to Abionic: Piccolo Xpress (Abaxis) (71/100), Abax Health (71/100), AccentCare (71/100), My Access 360 (71/100).
A step up - brands to learn from: Zymo Research (81/100), Zurich Insurance Group (81/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.